We demonstrated that severe COVID-19 was associated with elevated levels of numerous plasma mediators indicative of coagulation, endothelial activation and a broad inflammatory response including CXCL10, GM-CSF, and IL-6. The gene discussed is IL6; the disease is COVID-19.